A new era in Alzheimer’s treatment: FDA approval on lecanemab

January 11, 2023

Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is an “accelerated approval” of the […]

Texas Public Radio: Clinical trial for first Alzheimer’s drug with effect on cognitive decline looks for South Texas recruits

December 9, 2022

Arash Salardini, MD, neurologist at the Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed for this story on Texas Public Radio (KSTX) on a clinical trial in South Texas for a drug to treat cognitive decline. The clinical trial, AHEAD 3-45, is to assess whether IV infusions of the antibody (lecanemab) can delay cognitive […]

Can Alzheimer’s disease be delayed or stopped before the symptoms begin? A new clinical trial strives to find answers.

December 1, 2022

The AHEAD clinical trial will assess whether the new Alzheimer’s drug, lecanemab, can delay the onset of dementia in persons who are at high risk of developing the disease. Lecanemab has aroused some excitement recently and has been covered extensively by the media. A separate Phase III clinical trial, published Nov. 29 in The New England […] How to Spot the Warning Signs of Brain Trauma — And Prevent the Injuries That Lead to It

November 28, 2022

Did you know you can have chronic traumatic encephalopathy (CTE) from head trauma even if you are not an athlete or have served in the military?   Chronic traumatic encephalopathy (CTE) is caused by repeated traumatic brain injuries. Most people are unaware they had brain trauma and ignore symptoms of CTE unless they are in […]

San Antonio Magazine: At SAMA, Those with Dementia Can Connect Memories Through Art

November 16, 2022

Melissa Flores, LPC, NCC, counselor of the Biggs Institute, discusses how the institute’s “ReCollections” art program creates space for connection for patients and their caregivers. To read the article, visit the San Antonio Magazine.

UT Health San Antonio Women Leaders in Medicine Recognized

November 14, 2022

More than 15 female UT Health San Antonio physicians were recognized as Women Leaders in Medicine for their contributions to medicine by the Bexar County Medical Society. From the Biggs Institute and collaborators of the Biggs Institute, Sudha Seshadri, MD, founding director of the Biggs Institute, and Sarah Horn, MD, neurologist, Sara E. Espinoza, MD, […]

Forbes: Foods Rich In Omega-3s May Boost Middle-Aged Brain Health, Research Finds

October 7, 2022

Claudia Satizabal, PhD, researcher and assistant professor at the Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, comments on her research regarding small consumption of fatty acids may help preserve brain function. To read the full article, visit

Study links omega-3s to improved brain structure, cognition at midlife

October 6, 2022

Holy mackerel! Could eating salmon, cod, tuna, herring or sardines keep our brains healthy and our thinking agile in middle age? New research makes this connection. Eating cold-water fish and other sources of omega-3 fatty acids may preserve brain health and enhance cognition in middle age, new evidence indicates. Having at least some omega-3s in […]

Next Avenue: As COVID-19 Subsides, Online Memory Cafes for Dementia Linger

September 30, 2022

Sara Masoud, MPH, a doctoral student and senior community outreach coordinator of the UT Health San Antonio School of Nursing’s Caring for the Caregiver program discusses the importance of memory cafes in addressing dementia. To read the article, visit

Dozens more genes linked with stroke; potential drug targets identified

September 28, 2022

Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) are part of an international team that discovered 61 additional genetic loci associated with stroke and six genes that are potential targets for drug therapy to prevent or treat stroke. The findings, published today (Sept. 28) in Nature, are […]